ED
HSBC icon

Exane Derivatives’s HSBC HSBC Stock Holding History

Exane Derivatives’s Portfolio HSBC Stock Details HSBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,714
Closed -$131K – 640
2016
Q2 		$131K Buy
+4,714
New +$133K 0.02% 224
2015
Q1 		– Sell
-53,811
Closed -$2.19M – 541
2014
Q4 		$2.19M Buy
+53,811
New +$2.29M 0.3% 64

Other funds holding HSBC

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Exane Derivatives's HSBC Position: Q3 2016 in Review

Exane Derivatives sold out of HSBC (HSBC) in Q3 2016, closing a stake of 4,714 shares — an estimated $131K sold.

Exane Derivatives first reported a position in HSBC in Q4 2014 and held it in 2 quarters. The position peaked at $2.19M in Q4 2014. 304 funds tracked by Wall St. Rank hold HSBC as of Q3 2016.

  • Exane Derivatives reported no remaining HSBC position as of Q3 2016 after selling out during the quarter.
  • Exane Derivatives sold 4,714 HSBC shares in Q3 2016, an estimated $131K.
  • Exane Derivatives first reported a position in HSBC in Q4 2014 and held it in 2 quarters.
  • Exane Derivatives's HSBC position peaked at $2.19M in Q4 2014.
  • 304 funds tracked by Wall St. Rank held HSBC as of Q3 2016.

Based on Exane Derivatives's 13F filing for Q3 2016, filed 26 Oct 2016.